NewGen plans to repurchase convertible notes and warrants to enhance capital structure and eliminate potential equity dilution.
Quiver AI Summary
NewGenIVF Group Limited announced its entry into a Repurchase and Forbearance Agreement with a significant investor to repurchase all outstanding convertible notes and warrants previously issued to the investor. This move aims to strengthen the company's capital structure by eliminating potential dilution associated with these securities and is expected to position NewGen's market capitalization more accurately relative to its net assets. The settlement will simplify the capital structure and enhance visibility for existing and prospective shareholders. The repurchase will occur through an installment payment plan extending to late 2027, with provisions for prepayment without penalty. NewGen's management believes this agreement represents a crucial turning point in reinforcing its equity value and supporting further strategic initiatives aimed at enhancing shareholder value.
Potential Positives
- NewGen's repurchase of all outstanding convertible notes and warrants strengthens its capital structure by eliminating potential equity dilution, which can lead to increased shareholder value.
- The company anticipates that a simplified capital structure will enhance investor visibility and align market capitalization more closely with its net asset value.
- Management believes that the settlement positions NewGen for improved long-term value, allowing for strategic investments and continued growth initiatives in its diversified operations.
Potential Negatives
- Repurchasing convertible notes and warrants involves a significant financial commitment through scheduled installment payments extending through late 2027, which may strain cash flow and impact liquidity.
- The settlement may not eliminate concerns from investors regarding the company's ability to meet future payment obligations, potentially leading to a lack of confidence in the company's financial stability.
- The press release highlights a reliance on forward-looking statements that contain inherent risks and uncertainties, suggesting potential vulnerabilities in strategic plans and operational execution.
FAQ
What is the purpose of NewGen's repurchase of convertible notes and warrants?
NewGen aims to strengthen its capital structure and eliminate potential dilution from existing securities.
How will NewGen's Settlement Agreement affect shareholder value?
The settlement is expected to enhance shareholder value by simplifying the capital structure and improving net asset visibility.
When will the settlement payments be completed?
The payments under the Settlement Agreement are scheduled to extend through late 2027, with no penalties for prepayment.
What is NewGen’s approach to investor visibility after the settlement?
NewGen believes that a clearer capital structure will allow the market to better recognize its intrinsic value and net assets.
What strategic initiatives is NewGen pursuing post-settlement?
NewGen is evaluating potential future financings and expanding its stake in K25.ai as part of its growth strategy.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$NIVF Insider Trading Activity
$NIVF insiders have traded $NIVF stock on the open market 6 times in the past 6 months. Of those trades, 4 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $NIVF stock by insiders over the last 6 months:
- FINANCIAL LP HRT has made 4 purchases buying 200,290 shares for an estimated $193,918 and 2 sales selling 150,262 shares for an estimated $118,975.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$NIVF Hedge Fund Activity
We have seen 3 institutional investors add shares of $NIVF stock to their portfolio, and 4 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- HRT FINANCIAL LP removed 9,083 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $20,527
- TOWER RESEARCH CAPITAL LLC (TRC) added 1,500 shares (+inf%) to their portfolio in Q1 2026, for an estimated $3,389
- UBS GROUP AG removed 1,086 shares (-84.4%) from their portfolio in Q1 2026, for an estimated $2,454
- SBI SECURITIES CO., LTD. removed 57 shares (-91.9%) from their portfolio in Q1 2026, for an estimated $128
- BANK OF AMERICA CORP /DE/ removed 9 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $6
- MORGAN STANLEY added 1 shares (+inf%) to their portfolio in Q1 2026, for an estimated $2
- JPMORGAN CHASE & CO added 1 shares (+inf%) to their portfolio in Q4 2025, for an estimated $0
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
Full Release
NewGen to repurchase all outstanding convertible notes and warrants previously held by a significant investor in move to strengthen its capital structure
Settlement to eliminate potential dilution from convertible notes and warrants
Company views that this will position the Company’s market capitalization to be undervalued relative to net assets
BANGKOK, June 16, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (Nasdaq: NIVF) (“NewGen” or the “Company”) today announced that it has entered into a Repurchase and Forbearance Agreement (the “Settlement Agreement”) with a significant investor (the “Investor”). Under the terms of the Settlement Agreement, NewGen will repurchase all outstanding convertible notes and warrants previously issued to the Investor (the “Original Securities”) pursuant to the securities purchase agreements entered into between the parties in August 2024 and April 2025 (the “Existing Securities Purchase Agreements”), and the Investor will forbear from converting the outstanding convertible notes, exercising the outstanding warrants, and effectuating additional closings under the Existing Securities Purchase Agreements, subject to the terms of the Settlement Agreement.
The Original Securities consist of senior convertible notes and certain warrants issued under the Existing Securities Purchase Agreements, the outstanding amounts and terms of which are set forth in the Settlement Agreement and the Company’s prior filings with the SEC.
Effective as of today, the Investor shall forbear conversion of existing notes, exercise of warrants, and effectuating additional closings under the Existing Securities Purchase Agreements, for so long as the Company is not in default of its obligations thereunder. The convertible notes will be repurchased and cancelled upon full payment of the note purchase price, and the warrants will be repurchased and cancelled upon full payment of the warrant purchase price, removing potential equity dilution.
The Company expects to emerge from the Settlement Agreement with a more simplified capital structure that provides greater clarity for existing and prospective shareholders.
The aggregate consideration under the Settlement Agreement is payable pursuant to a scheduled instalment payment plan extending through late 2027. The Company may prepay all or any portion of the outstanding amounts at any time without penalty. Details of the Settlement Agreement may be viewed in the Company’s Form-6-K filed with the SEC today.
Management and the board believe that the extinguishment of the potential dilution represents a meaningful reset for the Company’s capital structure and equity value profile. Following the removal of these instruments, management believes the Company’s equity value will more accurately reflect its underlying net asset position and long-term value potential. The Company views that it is better positioned for improved investor visibility and continued execution of initiatives intended to enhance shareholder value.
Alfred Siu, Founder, Chairman and Chief Executive Officer of NewGen, commented, “This settlement represents a pivotal moment for NewGen. By eliminating potential dilution from the convertible note and warrants, we believe we are strengthening our capital structure. With a clear capital structure, we believe the market will have greater clarity to recognize the intrinsic value of our diversified portfolio of assets. We remain committed to executing on our strategic initiatives and delivering long-term value for our shareholders.”
The Company will continue to evaluate strategic alternatives to further enhance shareholder value, including potential future financings that do not carry similar dilutive overhang structures. With a clean capital structure in place, the Company is better positioned to pursue value-accretive strategic investments, including the potential expansion of its existing stake in K25.ai. In parallel, management recently adopted a Digital Asset Treasury strategy as part of its broader plan to diversify reserve assets and enhance long-term shareholder value.
About NewGenIVF Group Limited
NewGenIVF Group is a tech-forward, diversified, multi-jurisdictional growth company pursuing opportunities across real estate development, digital asset innovation and reproductive health solutions. The Company operates through “NewGenProperty,” focused on real estate development projects in the UAE’s Ras Al Khaimah Emirate; “NewGenDigital,” focused on digital asset and DeFi solutions; and “NewGenSup,” focused on health and longevity products and solutions. NewGenIVF’s legacy business involves IVF and assisted reproductive treatment services across Asia. To learn more, visit www.nivf.global. The information contained on, or accessible through, NewGenIVF’s website is not incorporated by reference into this press release and should not be considered part of this press release.
Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, Section 27A of the Securities Act of 1933, as amended, and the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates," "confident," "committed," "positioned," "outlook," "would," "may," "potential," "aim," "seek," "project," and similar expressions, or their negatives, although not all forward-looking statements contain these identifying words.
Forward-looking statements in this press release include, but are not limited to, statements that: the Company will repurchase all outstanding convertible notes and warrants previously issued to the Investor; the anticipated effect of the Settlement Agreement and the Investor's forbearance in reducing near-term conversion and exercise risk and simplifying the Company's capital structure; the expectation that the Company is better positioned for improved investor visibility, and that the market would recognise its net asset value; the Company's ability to satisfy its scheduled instalment payment obligations through late 2027 and to exercise the optional prepayment feature; the Company's stated intention to pursue the potential expansion of its existing stake in K25.ai; management's planned implementation of its Digital Asset Treasury strategy; and the Company's stated intention to continue evaluating opportunities to further strengthen its balance sheet and capital structure.
These forward-looking statements are based on the Company's current expectations, estimates, projections and assumptions as of the date of this press release and are subject to known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to differ materially from those expressed or implied. These risks and uncertainties include, among others: the risk that the Company fails to meet one or more of its scheduled installment payment obligations, which could result in termination of the Investor's forbearances and reinstatement of the Investor's conversion, exercise and additional closing rights; market risks which may impact investor visibility and market recognition of the Company’s value; the Company's ability to maintain sufficient liquidity to fund ongoing operations and satisfy its payment obligations under the Settlement Agreement through late 2027; risks associated with the Company's Digital Asset Treasury strategy, including the price volatility of digital assets; evolving and uncertain regulatory treatment of digital assets and staking activities; management's limited prior experience in the digital asset sector; risks related to the Company's ongoing business transformation and the strain such transformation places on management and operational resources; the risk that the Company's potential expansion of its stake in K25.ai or the valuation of that investment is not realized or declines; and other risks and uncertainties described in the Company's Annual Report on Form 20-F and the Company's other filings with the U.S. Securities and Exchange Commission.
All information provided in this press release is as of the date of this press release. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date of this press release.
Contacts
ICR, LLC
Robin Yang
Phone: +1 (212) 537-3847
Email:
[email protected]